Sublocade
Payments companies reported to CMS as associated with Sublocade. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Sublocade, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Sublocade
These are the largest totals companies reported as associated with Sublocade. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Arwen Podesta | New Orleans, LA | Psychiatry | $49,990.88 |
| William Santoro | West Reading, PA | Addiction Medicine (Family Medicine) | $25,099.29 |
| Brian Gadbois | Tampa, FL | Addiction Medicine (Psychiatry & Neurology) | $20,922.40 |
| Mark Grant | Tucson, AZ | Family Medicine | $20,493.95 |
| Mark Murphy | Gig Harbor, WA | Addiction Medicine (Family Medicine) | $19,345.43 |
| Paul Romo | Albuquerque, NM | Addiction Psychiatry | $16,364.30 |
| Christina Jones | Sulphur, LA | Addiction Medicine (Internal Medicine) | $16,220.42 |
| Laura Kehoe | Attleboro, MA | Addiction Medicine (Internal Medicine) | $15,677.09 |
| Nicole Labor | Akron, OH | Addiction Medicine (Family Medicine) | $14,892.04 |
| Enrique Oviedo | Dundalk, MD | Psychiatry | $14,087.02 |
Prescribed Sublocade?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.